MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$317,784K
Cash, cash
equivalents and restricted...
$80,213K
Inventory
$45,690K
Accounts receivable, net
$41,454K
Prepaid expenses and
deposits
$5,746K
Other current assets
$1,080K
Total current assets
$491,967K
Deferred tax assets, net
$176,194K
Finance right-of-use
lease assets
$73,865K
Intangible assets, net
$3,761K
Operating right-of-use
lease assets
$3,596K
Property and equipment,
net
$2,111K
Other noncurrent
assets
$93K
Total assets
$751,587K
Total liabilities and
shareholders' equity
$751,587K
Total shareholders'
equity
$581,331K
Total liabilities
$170,256K
Accumulated deficit
-$649,368K
Accumulated other
comprehensive loss
-$599K
Common shares - no par
value, unlimited...
$1,120,035K
Total current
liabilities
$93,724K
Finance lease
liabilities, less current...
$52,322K
Deferred revenue, less
current portion
$12,648K
Deferred compensation
and other...
$6,662K
Operating lease
liabilities, less current...
$4,900K
Additional paid-in capital
$111,263K
Accrued expenses
$66,621K
Finance lease
liabilities, current portion
$16,523K
Deferred revenue
$3,720K
Accounts payable
$3,313K
Other current
liabilities
$2,480K
Operating lease
liabilities, current portion
$1,067K
Back
Back
Balance Sheet
source: myfinsight.com
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)